Lab Leadership Summit
The one-day G2 Intelligence Lab Leadership Summit was a deep-dive into laboratory reimbursement and coding issues, stressing how labs can comply with new and existing rules and regulations to remain compliant, avoid payment delays, and maximize lab revenue, cash flow, and profitability under the latest rules.
This summit represented a unique opportunity to meet with your peers to discover specific ideas, tips and techniques that can help you to:
- Maximize reimbursements for diagnostic lab testing under PAMA and the new weighted private payor rates
- Maintain lab test volume and revenue to the maximum extent possible despite cutbacks
- Adjust quickly and easily to the new rates, new codes, and new reimbursement rules and guidelines
With the upcoming January deadlines, regardless of if you are an independent lab, hospital lab, or part of a large lab organization, you are facing cuts in Medicare reimbursements due to PAMA.
CMS estimates that Medicare spending on lab testing could be slashed by over $650 million in 2018 alone and under the new weighted private payor rates, almost three quarters of all test codes on the revised CLFS will have reduced payment amounts.
XiFin was proud to participate as a speaker and a Silver Sponsor at the Lab Leadership Summit.
Drastic Fee Cuts and Decreasing Coverage: Reimbursement and Regulatory Challenges for Diagnostics in 2018
Kyle Fetter, VP & General Manager of Diagnostic Services, XiFin, Inc.
60-minute presentation
Time: 8:30 AM-9:30 AM PT / 10:30 AM-11:30 AM CT / 11:30 AM-12:30 AM ET
Additional Conference Speakers
Jeffery H. Myers, CPA, Vice President of Consulting, Accumen Inc.
Ellen Neiduski, Managing Director, FTI Consulting
Diana Voorhees, Principal, DV & Associates, Inc.
Andrew B. Wachler, Managing Partner, Wachler Associates
G2 Intelligence provides timely, accurate and trusted analysis of industry and market trends, legal and regulatory developments, and technology and innovation that directly affect the operations, financial performance, and competitive position of diagnostic testing laboratories and related medical services providers. The company has covered and reported on the diagnostic industry for over 30 years.